John Deiriggi

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa.

Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL.

Mylan Technologies, Inc. designs, develops, and manufactures transdermal drug delivery systems, and associated materials and technologies. The company is headquartered in St. Albans, VT.

The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Eurofins Advinus Ltd. engages in the provision of research and development services that supports the discovery and development of compounds for diverse industries. The firm's services include drug and agrochemical discovery and development, biologics testing, and REACH (Registration, Evaluation, and Authorization of Chemicals) support. It serves the pharmaceuticals, biologicals, agrochemicals, nutraceuticals, and cosmetics markets. The company was founded by Kasim A. Mookhtiar in 2005 and is headquartered in Bangalore, India.

Graposs Edutech Pvt Ltd. operates Graposs Connect, a marketplace that combines education and technology. Over the past decade, the private company has worked in multiple ecosystems and leveraged access, technology, platforms, and stakeholder ecosystems to build knowledge in various domains of education and technology. The company is based in New Delhi, India. The Indian company offers various products, including Sarkari Pariksha, Naukri Connect, School LMS, College Admissions, and Olympiads. The Graposs Connect team is composed of professionals who aim to reach millions of people across India.

Biocon Biologics India Ltd. operates as a biotech company. It develops treatments for chronicle diseases. The company is headquartered in Bengaluru, India.